Nauck, Michael A <br/><br/>
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial.  [electronic resource] 

 -  Diabetes care  10 2019 
 - 1912-1920 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc19-0415  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Cardiovascular Diseases--etiology<br/>Cholecystitis--chemically induced<br/>Cholestasis--chemically induced<br/>Diabetes Mellitus, Type 2--complications<br/>Double-Blind Method<br/>Female<br/>Gallstones--chemically induced<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Liraglutide--adverse effects<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Treatment Outcome